RespireRx Pharmaceuticals Inc (RSPI): It's more of a question for clinicians,...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	4
Posts	1330
Boards Moderated	0
Alias Born	01/01/2007

enemem

Re: RBlatch post# 19702

Thursday, 08/07/2008 4:57:25 PM

Thursday, August 07, 2008 4:57:25 PM

It's more of a question for clinicians, but that's always looked like a logical next step, considering the fatalities that occur with some regularity among those chronically taking opiates for intractable pain.
If Cephalon partners with cor, my guess is this is the primary reason.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent RSPI News

Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 12:45:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 12:30:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 08:01:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 01:03:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:45:26 PM